Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything
Focused on therapies for rare blood disorders, this biotech saw a notable insider sale amid ongoing clinical development efforts.
Source: www.fool.com
Focused on therapies for rare blood disorders, this biotech saw a notable insider sale amid ongoing clinical development efforts.